2025年末医药行业掀起一股资产剥离热潮,涉及海王生物、丽珠医药等

动脉网
Dec 31, 2025

2025年末医药行业掀起资产剥离热潮,海王生物、丽珠医药等多家药企密集发布股权转让公告。海王生物12月30日公告,控股子公司河南海王拟2.48亿元转让河南东森100%股权,因行业政策变化致河南东森盈利能力下滑,此次剥离旨在优化资产结构,聚焦高毛利赛道。同日,丽珠医药公告与健康元等订立协议,交易完成后公司持有毛孩子股权摊薄,健康元不再持股,毛孩子不再纳入合并报表,此举利于公司聚焦主业、提升治理效能。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10